FDA Approved: XPOVIO — Original Application (Karyopharm Therapeutics Inc.)

View source ↗

Summary

The FDA approved XPOVIO (selinexor) from Karyopharm Therapeutics as a new drug application for the treatment of adult patients with relapsed or refractory multi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• XPOVIO (selinexor)

Snippet

ORIG AP for XPOVIO (SELINEXOR)